Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$23.14 - $34.72 $199,582 - $299,460
8,625 New
8,625 $251,000
Q4 2023

Feb 14, 2024

SELL
$34.21 - $44.59 $1,299 - $1,694
-38 Reduced 0.16%
24,279 $1.06 Million
Q3 2023

Nov 14, 2023

SELL
$37.8 - $45.97 $4,611 - $5,608
-122 Reduced 0.5%
24,317 $928,000
Q2 2023

Aug 14, 2023

BUY
$37.95 - $58.98 $927,460 - $1.44 Million
24,439 New
24,439 $1.01 Million
Q1 2021

May 14, 2021

SELL
$62.63 - $71.15 $7.58 Million - $8.61 Million
-121,024 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$43.31 - $66.55 $122,134 - $187,671
-2,820 Reduced 2.28%
121,024 $7.86 Million
Q3 2020

Nov 16, 2020

SELL
$43.33 - $51.72 $1.06 Million - $1.26 Million
-24,402 Reduced 16.46%
123,844 $5.85 Million
Q2 2020

Aug 14, 2020

SELL
$41.42 - $55.57 $10,065 - $13,503
-243 Reduced 0.16%
148,246 $6.97 Million
Q1 2020

May 15, 2020

SELL
$36.67 - $61.04 $3.82 Million - $6.36 Million
-104,181 Reduced 41.23%
148,489 $6.63 Million
Q4 2019

Feb 14, 2020

SELL
$55.73 - $62.49 $1.03 Million - $1.15 Million
-18,439 Reduced 6.8%
252,670 $14.7 Million
Q3 2019

Nov 14, 2019

BUY
$53.29 - $64.59 $4.89 Million - $5.92 Million
91,715 Added 51.12%
271,109 $16.3 Million
Q2 2019

Aug 14, 2019

BUY
$46.45 - $55.85 $3.69 Million - $4.43 Million
79,378 Added 79.37%
179,394 $10 Million
Q1 2019

May 13, 2019

BUY
$42.97 - $57.33 $306,590 - $409,049
7,135 Added 7.68%
100,016 $5.57 Million
Q4 2018

Feb 12, 2019

SELL
$42.62 - $64.51 $1.74 Million - $2.64 Million
-40,914 Reduced 30.58%
92,881 $4.19 Million
Q3 2018

Nov 14, 2018

BUY
$57.63 - $65.87 $7.71 Million - $8.81 Million
133,795 New
133,795 $8.81 Million

Others Institutions Holding IART

About INTEGRA LIFESCIENCES HOLDINGS CORP


  • Ticker IART
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 83,518,200
  • Market Cap $1.85B
  • Description
  • Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...
More about IART
Track This Portfolio

Track Kennedy Capital Management, Inc. Portfolio

Follow Kennedy Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kennedy Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Kennedy Capital Management, Inc. with notifications on news.